The single maintenance and reliever therapy (SMART) treatment approach to patients with asthma, outlined in the article on chronic asthma treatment in the April issue of American Family Physician, has consistent supporting evidence from multiple randomized controlled trials. A
THANK YOU for talking about this conflict of interest problem with asthma treatment guidelines. When the guidelines first came out in 2019, I felt like I was the only person who was skeptical about them. I have come to see that there is some wisdom in them, although my practice in Kenya is limited because of the cost of combined ICS/LABA inhalers in our context. But the guidelines deserve way more debate.
THANK YOU for talking about this conflict of interest problem with asthma treatment guidelines. When the guidelines first came out in 2019, I felt like I was the only person who was skeptical about them. I have come to see that there is some wisdom in them, although my practice in Kenya is limited because of the cost of combined ICS/LABA inhalers in our context. But the guidelines deserve way more debate.